Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more.
Front Pharmacol
; 14: 1222209, 2023.
Article
in En
| MEDLINE
| ID: mdl-37361211
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland